Original item no,Original recommendation,Adapted item no,Adapted question (words in square brackets are added)
1a,(a) Indicate the study’s design with a commonly used term in the title or the abstract,1a,"Indicate the study’s design [as cross-sectional, cohort or case-control] in the title or the abstract"
1b,(b) Provide in the abstract an informative and balanced summary of what was done and what was found,1b_i,Provide in the abstract an informative and balanced summary of what was done
1b,,1b_ii,Provide in the abstract an informative and balanced summary of what was found
2,Explain the scientific background and rationale for the investigation being reported,2_i,Explain the scientific background for the investigation being reported
2,,2_ii,Explain the rationale for the investigation being reported
3,"State specific objectives, including any prespecified hypotheses",3,
4,Present key elements of study design early in the paper,4,
5,"Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection",5_i,Describe the setting
5,,5_ii,Describe the locations
5,,5_iii,"Describe the relevant dates, including periods of recruitment"
5,,5_iv,"Describe the relevant dates, including periods of exposure"
5,,5_v,"Describe the relevant dates, including periods of follow-up"
5,,5_vi,"Describe the relevant dates, including periods of data collection"
6a,"(a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up. Case-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls. Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants",6a_i_coh_cs,[Cohort and cross-sectional studies] – Give the eligibility criteria
6a,,6a_ii_coh_cs,[Cohort and cross-sectional studies] – Give the sources of participants.
6a,,6a_iii_coh_cs,[Cohort and cross-sectional studies] – Give the methods of selection of participants
6a,,6a_iv_coh,Cohort study - Describe methods of follow-up
6a,,6a_i_cc,Case-control study - Give the eligibility criteria
6a,,6a_ii_cc,Case-control study – Give the sources of case ascertainment and control selection
6a,,6a_iii_cc,Case-control study – Give the methods of case ascertainment and control selection.
6a,,6a_iv_cc,Case-control study – Give the rationale for the choice of cases and controls
6b,"(b) Cohort study—For matched studies, give matching criteria and number of exposed and unexposed. Case-control study—For matched studies, give matching criteria and the number of controls per case",6b_i_coh,"Cohort study - For matched studies, give matching criteria"
6b,,6b_ii_coh,"Cohort study - For matched studies, give number of exposed and unexposed"
6b,,6b_i_cc,"Case-control study - For matched studies, give matching criteria"
6b,,6b_ii_cc,"Case-control study - For matched studies, give the number of controls per case"
7,"Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable",7_i,Clearly define all outcomes
7,,7_ii,Clearly define all exposures
7,,7_iii,Clearly define all predictors
7,,7_iv,Clearly define all potential confounders
7,,7_v,Clearly define all effect modifiers
7,,7_vi,"Give diagnostic criteria, if applicable"
8*,"For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group",8starred_i,"For each variable of interest, give sources of data"
8*,,8_star_i_cc,[Case-control studies] - Give information separately for cases and controls
8*,,8_star_i_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
8*,,8starred_ii,"For each variable of interest, give details of methods of assessment (measurement)"
8*,,8_star_ii_cc,[Case-control studies] - Give information separately for cases and controls
8*,,8_star_ii_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
8*,,8starred_iii,Describe comparability of assessment methods if there is more than one group
8*,,8_star_iii_cc,[Case-control studies] - Give information separately for cases and controls
8*,,8_star_iii_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
9,Describe any efforts to address potential sources of bias,9,9. Describe any efforts to address potential sources of bias [(does not include any adjustment for confounders)]
10,Explain how the study size was arrived at,10,
11,"Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why",11_i,Explain how quantitative variables were handled in the analyses
11,,11_ii,"If applicable, describe which groupings were chosen and why"
11,,11_iii,"If applicable, describe why groupings were chosen "
12a,"(a) Describe all statistical methods, including those used to control for confounding",12a,
12b,(b) Describe any methods used to examine subgroups and interactions,12b_i,Describe any methods used to examine subgroups
12b,,12b_ii,Describe any methods used to examine interactions
12c,(c) Explain how missing data were addressed,12c,
12d,"(d) Cohort study—If applicable, explain how loss to follow-up was addressed. Case-control study—If applicable, explain how matching of cases and controls was addressed. Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy",12d_coh,"Cohort study—If applicable, explain how loss to follow-up was addressed"
12d,,12d_cc,"Case-control study—If applicable, explain how matching of cases and controls was addressed"
12d,,12d_cs,"Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy"
12e,(e) Describe any sensitivity analyses,12e,
13*a,"(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed",13starreda,"Report numbers of individuals at each stage of [the present] study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed"
13*a,,13_star_a_cc,[Case-control studies] - Give information separately for cases and controls
13*a,,13_star_a_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
13*b,(b) Give reasons for non-participation at each stage,13starredb,Give reasons for non-participation at each stage [of the present study]
13*b,,13_star_b_cc,[Case-control studies] - Give information separately for cases and controls
13*b,,13_star_b_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
13*c,(c) Consider use of a flow diagram,13starredc,[Use a] flow diagram [if appropriate]
13*c,,13_star_c_cc,[Case-control studies] - Give information separately for cases and controls
13*c,,13_star_c_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
14*a,"(a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders",14starreda_i,"Give characteristics of study participants (eg demographic, clinical, social)"
14*a,,14_star_a_i_cc,[Case-control studies] - Give information separately for cases and controls
14*a,,14_star_a_i_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
14*a,,14starreda_ii,Give information on exposures and potential confounders
14*a,,14_star_a_ii_cc,[Case-control studies] - Give information separately for cases and controls
14*a,,14_star_a_ii_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
14*b,(b) Indicate number of participants with missing data for each variable of interest,14starredb,
14*b,,14_star_b_cc,[Case-control studies] - Give information separately for cases and controls
14*b,,14_star_b_coh_cs,[Cohort and cross-sectional studies] - Give information separately for exposed and unexposed groups
14*c,"(c) Cohort study—Summarise follow-up time (eg, average and total amount)",14starredc_coh,
14*c,,14_star_c_coh,[Cohort studies] - Give information separately for exposed and unexposed groups
15*,Cohort study—Report numbers of outcome events or summary measures over time,15starred_coh,
15*,,15_star_coh,[Cohort studies] - Give information separately for exposed and unexposed groups
15*,"Case-control study—Report numbers in each exposure category, or summary measures of exposure",15starred_cc,
15*,,15_star_cc,[Case-control studies] - Give information separately for cases and controls
15*,Cross-sectional study—Report numbers of outcome events or summary measures,15starred_cs,
15*,,15_star_cs,[Cross-sectional studies] - Give information separately for exposed and unexposed groups
16a,"(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included",16a_i,Give unadjusted estimates
16a,,16a_ii,"if applicable, [give] confounder-adjusted estimates "
16a,,16a_iii,"if applicable, [give] confounder-adjusted estimates’ their precision (eg, 95% confidence interval)."
16a,,16a_iv,Make clear which confounders were adjusted for
16a,,16a_v,Make clear why confounders were included
16b,(b) Report category boundaries when continuous variables were categorized,16b,
16c,"(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period",16c,
17,"Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses",17_i,Report analyses of subgroups
17,,17_ii,Reports analyses of interactions
17,,17_iii,Report sensitivity analyses
17,,17_iv,Report other analyses done
18,Summarise key results with reference to study objectives,18,
19,"Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias",19_i,"Discuss limitations of the study, taking into account sources of potential bias or imprecision."
19,,19_ii,Discuss both direction and magnitude of any potential bias
20,"Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence",20,
21,Discuss the generalisability (external validity) of the study results,21,
22,"Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based",22_i,Give the source of funding for the present study
22,,22_ii,Give the role of the funders for the present study
22,,22_iii,"If applicable, give the source of funding for the original study on which the present article is based"
22,,22_iv,"If applicable, give the role of the funders for the original study on which the present article is based"
